Celecoxib and Curcumin Additively Inhibit the Growth of Colorectal Cancer in a Rat Model

Abstract

In vivo, curcumin augments the growth inhibitory effect of celecoxib. This may be clinically important as this dose of celecoxib can be achieved in human serum following standard anti-inflammatory dosing of 100 mg.